Esteban Celis

GRA/Whitaker Eminent Scholar in Cancer

Esteban Celis

GRA/Whitaker Eminent Scholar in Cancer

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Medicine: Hematology and Oncology

The Graduate School
Department of Graduate Studies

Medical College of Georgia
Department of Biochemistry and Molecular Biology

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Bio

Dr. Celis received his MD, MSc, and PhD degrees from the National University of Mexico. He was a Fogarty International Fellow at the Center for Cancer Research at Massachusetts Institute of Technology.

Education

  • Ph.D., Biomedical Sci , General Ntnl Autonomous Univ of Mexico, 1981

  • MD, Medicine (MD) Ntnl Autonomous Univ of Mexico, 1977

  • MS, Biomedical Sci , General Ntnl Autonomous Univ of Mexico, 1976

Awards & Honors

  • Outstanding Investigator Awards 2015

  • Invited Guest Lecturer Award 2013

Courses Taught Most Recent Academic Year

  • BCMB 9300

    Research
  • MOLM 9300

    Research
  • COGS 8215

    Fundamentals of Oncology I
  • COGS 8240

    Intro to Imm/Inf Disease
  • MOLM 9210

    Invest of a Problem
  • BCMB 9210

    Investigation of Problem

Teaching Interests

Immunology, Tummor immunology

Scholarship

Selected Recent Publications

  • CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma, 2015
    Journal Article, Academic Journal
  • Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells, 2015
    Journal Article, Academic Journal
  • Mutated BRAF emerges as a major effector of recurrence in a murine melanoma model after treatment with immunomodulatory agents, 2015
    Journal Article, Academic Journal
  • STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice, 2015
    Journal Article, Academic Journal
  • A novel combinatorial cancer immunotherapy: Poly-IC and blockade of the PD-1/PD-L1 pathway, 2014
    Journal Article, Academic Journal

Research Interests

Tumor Immunology, Vaccines